Risk Profile and 1-Year Outcome of Newly Diagnosed Atrial Fibrillation in Japan - Insights From GARFIELD-AF -


Creative Commons License

Koretsune Y., Etoh T., Katsuda Y., Suetsugu T., Kumeda K., Sakuma I., ...Daha Fazla

CIRCULATION JOURNAL, cilt.83, sa.1, ss.67-97, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 83 Sayı: 1
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1253/circj.cj-18-0655
  • Dergi Adı: CIRCULATION JOURNAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.67-97
  • Anahtar Kelimeler: GARFIELD-AF, Non-valvular atrial fibrillation, Oral anticoagulation, STROKE, WARFARIN, REGISTRY, THERAPY
  • Dokuz Eylül Üniversitesi Adresli: Hayır

Özet

Background: Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective non-interventional study of stroke prevention in patients with newly diagnosed non-valvular AF (NAVF) that is being conducted in 35 countries.